Regeneron Pharmaceuticals | REGN - Текущие активы

Биржевая цена
686.66
Изменение за день
-45.11 -6.16%
Ежемесячно
-8.36%
Ежегодный
14.68%
Q2 прогноз
735.49




Текущие активы Изменить Дата
AbbVie USD 29.06B 523M 2025-12
Agenus USD 133.44M 514K 2025-12
Agios Pharmaceuticals USD 834.84M 107.21M 2026-03
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Amgen USD 29.06B 1.17B 2025-12
Astellas Pharma JPY 1.42T 19.35B 2026-03
AstraZeneca USD 29.61B 890M 2026-03
Biogen USD 9.19B 216.3M 2026-03
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Eli Lilly USD 55.63B 6.44B 2025-12
Esperion Therapeutics USD 462.57M 102.11M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Incyte USD 5.48B 460.36M 2026-03
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
J&J USD 59.17B 3.55B 2026-03
Kyowa Hakko Kirin JPY 493.35B 2.55B 2025-12
Merck USD 47.56B 10.49B 2025-09
Moderna USD 6.54B 54M 2025-12
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Novartis USD 30.46B 2.26B 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.95B 8.99B 2025-12
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
United Therapeutics USD 3.7B 208.5M 2025-12
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12